publication venue for
- Device-detected atrial fibrillation before and after acute cardiac events: insights from ASSERT 2021
- Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis 2019
- Diagnostic reliability of monitoring for premature atrial and ventricular complexes. 26:euae198. 2024
- Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS. 26:euae183. 2024
- Association of the pattern of new-onset post-operative atrial fibrillation with adverse clinical events over 1 year follow-up: insights from the VISION Cardiac Surgery Cohort. 26:euae102.014. 2024
- Clinical significance of new-onset atrial fibrillation in patients with coronary artery or peripheral artery disease: results from the COMPASS trial. 26:euae102.024. 2024
- Dietary sodium intake and atrial myopathy. 26:euae102.017. 2024
- Effects of long-term continuous screening for atrial fibrillation on heart failure events - results from the randomized LOOP Study. 26:euae102.050. 2024
- Incidence and predictors of heart failure events following cardiac surgery in patients with atrial fibrillation - insights from the LAAOS-III trial. 26:euae102.051. 2024
- Timing of detection of atrial fibrillation recurrence in patients with transient new-onset atrial fibrillation detected during hospitalization for noncardiac surgery or medical illness. 26:euae102.018. 2024
- Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference. 26:euae070. 2024
- Durability of pulmonary vein isolation for atrial fibrillation: a meta-analysis and systematic review. 25:euad335. 2023
- Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation. 25:euad200. 2023
- Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation. 25:euad149. 2023
- Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke: comment—Authors’ reply. 25:778-778. 2023
- Techniques improving electrical cardioversion success for patients with atrial fibrillation: a systematic review and meta-analysis. 25:318-330. 2023
- Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference. 25:6-27. 2023
- Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis. 24:1548-1559. 2022
- Remote ECG monitoring to reduce complications following transcatheter aortic valve implantations: the Redirect TAVI study. 24:1475-1483. 2022
- A clinical dilemma: the longer the higher the risk?—Authors’ reply. 24:1196-1197. 2022
- Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke. 24:1058-1064. 2022
- Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial. 24:1112-1118. 2022
- New-onset perioperative atrial fibrillation in cardiac surgery patients: transient trouble or persistent problem?. 24:1037-1037. 2022
- Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study. 24:774-783. 2022
- Electrocardiogram screening programme in detecting sudden cardiac disease in the young: cost efficiency and diagnostic yield—Authors’ reply. 24:524-525. 2022
- Corrigendum to: Diagnostic yield and financial implications of a nationwide electrocardiographic screening program to detect cardiac disease in the young. 23:1301-1301. 2021
- Diagnostic yield and financial implications of a nationwide electrocardiographic screening programme to detect cardiac disease in the young. 23:1295-1301. 2021
- Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials. 23:1200-1210. 2021
- Antiplatelets in patients with atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials. 23:euab116.265. 2021
- Post-operative pain following cardiac implantable electronic device implantation: insights from the BRUISE CONTROL trials. 23:748-756. 2021
- Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. 23:329-344. 2021
- Mobile health applications for the detection of atrial fibrillation: a systematic review. 23:11-28. 2021
- 74Subclinical atrial fibrillation before and after acute medical illness or noncardiac surgery: insights from ASSERT. 22. 2020
- Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis. 22:870-877. 2020
- Atrial fibrillation and stroke: chicken or egg? Does it really matter?. 22:509-510. 2020
- The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events. 22:195-204. 2020
- Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme. 22:47-57. 2020
- A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the Prevention of Syncope Trial VI. 21:1733-1741. 2019
- Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial. 21:1023-1030. 2019
- Perspective and practice of surgical atrial fibrillation ablation: an international survey of cardiac surgeons. 21:445-450. 2019
- Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS. 21:421-427. 2019
- Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden. 21:377-382. 2019
- Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study. 20:1798-1803. 2018
- Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. 20:f240-f248. 2018
- Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. 20:1442-1450. 2018
- Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study. 20:e87-e95. 2018
- Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries. 20:963-970. 2018
- The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey. 20:929-934. 2018
- 47Characteristics and outcomes of atrial fibrillation in patients without conventional risk factors: A RE-LY AF registry analysis. 20:i5-i5. 2018
- ST segment depression on 24-hour electrocardiography predicts incident atrial fibrillation in two population-based cohorts. 20:429-434. 2018
- Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. 20:253-262. 2018
- Left atrial anatomy, atrial fibrillation burden, and P-wave duration—relationships and predictors for single-procedure success after pulmonary vein isolation. 20:271-278. 2018
- Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey. 19:1922-1929. 2017
- Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. 19:1630-1636. 2017
- Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). 19:1556-1578. 2017
- P1380Gender differences in the progression of atrial fibrillation in low-risk paroxysmal AF patients with hypertension: the role of left ventricular hypertrophy. 19:iii269-iii270. 2017
- P283The influence of progression of atrial fibrillation on quality of life: a report from the euro heart survey. 19:iii40-iii40. 2017
- Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial. 19:euw116-euw116. 2017
- Cost effectiveness of LAA closure in patients with AF and contraindications to warfarin: comment. 19:euw072-euw072. 2017
- Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis. 19:euw221-euw221. 2017
- Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation. 18:973-978. 2016
- The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: the EaSyAS II trial. 18:912-918. 2016
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. 18:159-183. 2016
- Usefulness of the Calgary Syncope Symptom Score for the diagnosis of vasovagal syncope in the elderly. 15:1210-1214. 2013
- Duty-cycled bipolar/unipolar radiofrequency ablation for symptomatic atrial fibrillation induces significant pulmonary vein narrowing at long-term follow-up. 15:690-696. 2013
- Heart failure in patients with sick sinus syndrome treated with single lead atrial or dual-chamber pacing: no association with pacing mode or right ventricular pacing site. 14:1475-1482. 2012
- Non-apical pacing: the right place to the right patient. 14:1376-1376. 2012
- Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. 14:682-689. 2012
- Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. 14:666-674. 2012
- Device-detected atrial tachyarrhythmias: what do we know?. 14:157-158. 2012
- Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. 14:184-190. 2012
- The value of cardiovascular hospitalization as an endpoint for clinical atrial fibrillation research. 13:601-602. 2011
- The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation. 13:409-415. 2011
- Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. 13:23-30. 2011
- Atrial overdrive pacing in sleep apnoea: a meta-analysis. 11:1037-1040. 2009
- Comprehensive upstream treatment for atrial fibrillation, when and how?. 11:397-399. 2009
- Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. 10:403-411. 2008
- Cardiac resynchronization therapy: left or left-and-right for optimal symptomatic effect the LOLA ROSE study. 9:862-868. 2007
- Central serotoninergic response to orthostatic challenge in patients with neurocardiogenic syncope. 8:306-311. 2006
- Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope Rationale and study design. 5:71-75. 2003